Myers Byron 4
4 · Inogen Inc · Filed Mar 16, 2021
Insider Transaction Report
Form 4
Inogen IncINGN
Myers Byron
Vice President, Marketing
Transactions
- Exercise/Conversion
Common Stock
2021-03-15$16.62/sh+7,102$118,035→ 44,429 total - Sale
Common Stock
2021-03-15$52.21/sh−3,052$159,356→ 37,327 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-15−7,102→ 0 totalExercise: $16.62Exp: 2021-03-31→ Common Stock (7,102 underlying) - Sale
Common Stock
2021-03-15$51.78/sh−4,050$209,692→ 40,379 total
Footnotes (3)
- [F1]Represents the weighted average share price of an aggregate total of 4,050 shares sold in the price range of $51.10 to $52.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 3,052 shares sold in the price range of $52.11 to $52.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014.